Asim Kichloo Michael S Albosta Shane McMahon Kimberly Movsesian Farah Wani Shakeel M Jamal Michael Aljadah Jagmeet Singh
10.1177/2324709620951339
J Investig Med High Impact Case Rep
2020 Jan-Dec;8:2324709620951339.
diabetic ketoacidosis immunotherapy pembrolizumab
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/32830561/
Adenocarcinoma / secondary Antineoplastic Agents, Immunological / adverse effects Colonic Neoplasms / drug therapy Diabetic Ketoacidosis / chemically induced
Adenocarcinoma / secondary Antineoplastic Agents, Immunological / adverse effects Colonic Neoplasms / drug therapy Diabetic Ketoacidosis / chemically induced Case Reports Adenocarcinoma / drug therapy Aged Antibodies, Monoclonal, Humanized Female Humans Immunotherapy / adverse effects Programmed Cell Death 1 Receptor / antagonists & inhibitors Antibodies, Monoclonal, Humanized Antineoplastic Agents, Immunological Programmed Cell Death 1 Receptor pembrolizumab
PMC7448133
32830561
Pembrolizumab-Induced Diabetes Mellitus Presenting as Diabetic Ketoacidosis in a Patient With Metastatic Colonic Adenocarcinoma
2020